Drug Profile
A 0001
Alternative Names: A-0001; alpha-tocopherol quinone; EPIA-0001Latest Information Update: 14 Aug 2018
Price :
$50
*
At a glance
- Originator Edison Pharmaceuticals
- Developer Endo Pharmaceuticals
- Class Coenzymes; Eye disorder therapies; Neuropsychotherapeutics
- Mechanism of Action Mitochondrial membrane transport protein stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Friedreich's ataxia; MELAS syndrome
Most Recent Events
- 01 Aug 2018 Edison Pharmaceuticals is now called BioElectron Technology
- 29 Feb 2012 Discontinued - Phase-II for Friedreich's ataxia in USA (PO)
- 29 Feb 2012 Discontinued - Phase-II for MELAS syndrome in England (PO)